Literature DB >> 23298206

Regulation of ligands for the NKG2D activating receptor.

David H Raulet1, Stephan Gasser, Benjamin G Gowen, Weiwen Deng, Heiyoun Jung.   

Abstract

NKG2D is an activating receptor expressed by all NK cells and subsets of T cells. It serves as a major recognition receptor for detection and elimination of transformed and infected cells and participates in the genesis of several inflammatory diseases. The ligands for NKG2D are self-proteins that are induced by pathways that are active in certain pathophysiological states. NKG2D ligands are regulated transcriptionally, at the level of mRNA and protein stability, and by cleavage from the cell surface. In some cases, ligand induction can be attributed to pathways that are activated specifically in cancer cells or infected cells. We review the numerous pathways that have been implicated in the regulation of NKG2D ligands, discuss the pathologic states in which those pathways are likely to act, and attempt to synthesize the findings into general schemes of NKG2D ligand regulation in NK cell responses to cancer and infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298206      PMCID: PMC4244079          DOI: 10.1146/annurev-immunol-032712-095951

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  142 in total

1.  Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

Authors:  Hai Li; Tadepally Lakshmikanth; Cinzia Garofalo; Martin Enge; Clemens Spinnler; Andrea Anichini; Laszlo Szekely; Klas Kärre; Ennio Carbone; Galina Selivanova
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.

Authors:  Sonja Textor; Nathalie Fiegler; Annette Arnold; Angel Porgador; Thomas G Hofmann; Adelheid Cerwenka
Journal:  Cancer Res       Date:  2011-07-15       Impact factor: 12.701

3.  Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.

Authors:  Anja Heinemann; Fang Zhao; Sonali Pechlivanis; Jürgen Eberle; Alexander Steinle; Sven Diederichs; Dirk Schadendorf; Annette Paschen
Journal:  Cancer Res       Date:  2011-11-18       Impact factor: 12.701

4.  Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis.

Authors:  Mingcan Xia; Nadia Guerra; Galina K Sukhova; Kangkang Yang; Carla K Miller; Guo-Ping Shi; David H Raulet; Na Xiong
Journal:  Circulation       Date:  2011-11-21       Impact factor: 29.690

5.  NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site.

Authors:  Da Lin; Hayley Lavender; Elizabeth J Soilleux; Christopher A O'Callaghan
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

6.  Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.

Authors:  Sonia Agüera-González; Catharina C Gross; Lola Fernández-Messina; Omodele Ashiru; Gloria Esteso; Howard C Hang; Hugh T Reyburn; Eric O Long; Mar Valés-Gómez
Journal:  Eur J Immunol       Date:  2011-11-03       Impact factor: 5.532

Review 7.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

8.  The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Authors:  Jason M Norman; Michael Mashiba; Lucy A McNamara; Adewunmi Onafuwa-Nuga; Estelle Chiari-Fort; Wenwen Shen; Kathleen L Collins
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

9.  Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.

Authors:  Maria Tokuyama; Clarisse Lorin; Frederic Delebecque; Heiyoun Jung; David H Raulet; Laurent Coscoy
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

Review 10.  The DNA damage response in viral-induced cellular transformation.

Authors:  P A Nikitin; M A Luftig
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

View more
  339 in total

Review 1.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

2.  A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Immunol Cell Biol       Date:  2016-01-06       Impact factor: 5.126

3.  Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients.

Authors:  Lin Xiao; Dongzhi Cen; Haining Gan; Yan Sun; Nanqi Huang; Hanzhen Xiong; Qiongmei Jin; Liqun Su; Xuejuan Liu; Kejian Wang; Guangrong Yan; Tianfa Dong; Shangbiao Wu; Pengzhi Zhou; Jinshan Zhang; Weixiang Liang; Junlan Ren; Yaoshu Teng; Can Chen; Xue Hu Xu
Journal:  Mol Ther       Date:  2019-03-20       Impact factor: 11.454

4.  Human dNK cell function is differentially regulated by extrinsic cellular engagement and intrinsic activating receptors in first and second trimester pregnancy.

Authors:  Jianhong Zhang; Caroline E Dunk; Melissa Kwan; Rebecca L Jones; Lynda K Harris; Sarah Keating; Stephen J Lye
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

5.  Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.

Authors:  Sudha Neelam; Jessamee Mellon; Amber Wilkerson; Jerry Y Niederkorn
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

6.  A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells.

Authors:  Fabian Wolpert; Isabel Tritschler; Alexander Steinle; Michael Weller; Günter Eisele
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

7.  T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.

Authors:  Man Li; Pengyan Xia; Ying Du; Shengwu Liu; Guanling Huang; Jun Chen; Honglian Zhang; Ning Hou; Xuan Cheng; Luyu Zhou; Peifeng Li; Xiao Yang; Zusen Fan
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

8.  Enhanced activation of human NK cells by drug-exposed hepatocytes.

Authors:  Frank Fasbender; Martin Obholzer; Sarah Metzler; Regina Stöber; Jan G Hengstler; Carsten Watzl
Journal:  Arch Toxicol       Date:  2020-02-14       Impact factor: 5.153

Review 9.  Exploring the NK cell platform for cancer immunotherapy.

Authors:  Jacob A Myers; Jeffrey S Miller
Journal:  Nat Rev Clin Oncol       Date:  2020-09-15       Impact factor: 66.675

Review 10.  The potential role for infections in the pathogenesis of autoimmune Addison's disease.

Authors:  A Hellesen; E Bratland
Journal:  Clin Exp Immunol       Date:  2018-09-30       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.